SCHEMBL2448486

SCHEMBL2448486

COc1cc(Cl)cc(C=NO)c1Cl

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.53
ERN1 O75460 1/20 0.49
HPGD P15428 3/20 0.47
TSHR P16473 2/20 0.47
ALDH1A1 P00352 3/20 0.44
KDM4E B2RXH2 2/20 0.44
KMT2A Q03164 5/20 0.40
MEN1 O00255 3/20 0.40
NPC1 O15118 2/20 0.40
NFKB1 P19838 2/20 0.40
RAB9A P51151 2/20 0.40
NFKB2 Q00653 2/20 0.40
RELA Q04206 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
PTK6 Q13882 1/20 0.39
MAPT P10636 4/20 0.38
HSD17B10 Q99714 1/20 0.38
HTT P42858 3/20 0.38
LMNA P02545 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2448485 1.00 GAA (0.53) GAAERN1HPGDTSHRALDH1A1
SCHEMBL2446271 0.84 GAA (0.63) GAAERN1HPGDTSHRALDH1A1
SCHEMBL2446274 0.84 GAA (0.63) GAAERN1HPGDTSHRALDH1A1
SCHEMBL24495458 0.79 HPGD (0.69) GAAHPGDTSHRALDH1A1KDM4E
SCHEMBL2447953 0.79 HPGD (0.69) GAAHPGDTSHRALDH1A1KDM4E
SCHEMBL2447956 0.79 HPGD (0.69) GAAHPGDTSHRALDH1A1KDM4E
SCHEMBL29687081 0.79 HPGD (0.69) GAAHPGDTSHRALDH1A1KDM4E
SCHEMBL28293621 0.76 ERN1 (0.68) GAAERN1HPGDTSHRALDH1A1
SCHEMBL15129432 0.75 GAA (0.44) GAAERN1HPGDTSHRALDH1A1
SCHEMBL20797186 0.75 HPGD (0.53) ERN1HPGDTSHRALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2366704-B1 Inhibitors of serine proteases VERTEX PHARMA (US) 2013-10-23 EP disclosed
EP-2631238-A1 Spirocyclic inhibitors of serine proteases for the treatment of hcv infections VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-08-28 EP disclosed
EP-1917269-B1 INHIBITORS OF SERINE PROTEASES VERTEX PHARMA (US) 2011-10-26 EP disclosed
EP-2366704-A1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-09-21 EP disclosed
EP-2364984-A1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-09-14 EP disclosed